40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Analyze analyst forecasts for the company and compare them with competitors.
9.97B
Better than CRK's estimated revenue of 1.96B.
1.99B
Better than CRK's estimated ebitda of 1.13B.
5.64
Better than CRK's estimated eps of 0.99.
1.57B
Better than CRK's estimated net income of 250.00M.
-30.08M
Worse than CRK's estimated ebit of 496.15M.
1.73B
Worse than CRK's estimated sg&a expense of 50.66M.
Analyze DCF forecasts for the company and compare them with competitors.
19.01B
Better than CRK's revenue of 5.63B.
15.56%
Worse than CRK's revenue growth rate of 37.70%.
3.80B
Better than CRK's ebitda of 3.25B.
20.00%
Worse than CRK's ebitda margin of 57.80%.
-57.36M
Worse than CRK's ebit of 1.43B.
-0.30%
Worse than CRK's ebit margin of 25.34%.
3.86B
Worse than CRK's depreciation of 1.83B.
201.88M
Better than CRK's total cash of 114.43M.
1.06%
Worse than CRK's cash as percentage of revenue of 2.03%.
2.70B
Worse than CRK's receivables of 960.38M.
14.23%
Better than CRK's receivables as percentage of revenue of 17.07%.
22.28M
Better than CRK's inventories of 24.48M.
0.12%
Better than CRK's inventories as percentage of revenue of 0.44%.
873.88M
Better than CRK's accounts payable of 1.44B.
4.60%
Better than CRK's payables as percentage of revenue of 25.63%.
-4.77B
Better than CRK's capital expenditure of -3.16B.
-25.11%
Worse than CRK's capex as percentage of revenue of -56.09%.
12.06%
Worse than CRK's weighted average cost of capital (wacc) of 6.15%.
16.87%
Worse than CRK's cost of equity of 6.67%.
5.31%
Better than CRK's cost of debt of 6.23%.
2.64
Worse than CRK's beta of 0.48.
263.90M
Better than CRK's diluted shares outstanding of 276.81M.
6.68B
Worse than CRK's total debt of 2.71B.
10.03B
Better than CRK's total equity of 4.25B.
16.71B
Better than CRK's total capital of 6.97B.
39.98%
Worse than CRK's debt weighting of 38.96%.
60.02%
Worse than CRK's equity weighting of 61.04%.
-52.47M
Worse than CRK's ebiat of 1.23B.
-1.22B
Worse than CRK's unlevered free cash flow of 21.26M.
0.50%
Equal to CRK's long-term growth rate of 0.50%.
-12.22B
Worse than CRK's terminal value of 520.34M.
-10.90B
Worse than CRK's enterprise value of 313.25M.
6.68B
Worse than CRK's net debt of 2.70B.
-17.58B
Worse than CRK's equity value of -2.38B.
-66.63
Worse than CRK's equity value per share of -8.61.
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Analysts expect the stock price to increase by 27.11%.
Buy
Positive consensus among analysts.
